Myriad Genetics
MYGN
#7437
Rank
NZ$0.77 B
Marketcap
NZ$8.18
Share price
-5.71%
Change (1 day)
-33.21%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2025 (TTM): -NZ$0.7 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are NZ$0.82 Billion. In 2024 the company made an earning of -NZ$0.21 Billion, an increase over its 2023 earnings that were of -NZ$0.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.7 Billion238.61%
2024 -NZ$0.21 Billion-53.49%
2023 -NZ$0.45 Billion88.72%
2022 -NZ$0.24 Billion172.08%
2021 -NZ$86.24 Million
2019 -NZ$44.92 Million-175.14%
2018 NZ$59.76 M-70.81%
2017 NZ$0.20 B22.22%
2016 NZ$0.16 B-38.8%
2015 NZ$0.27 B-6.12%
2014 NZ$0.29 B-41.07%
2013 NZ$0.49 B46.67%
2012 NZ$0.33 B15.84%
2011 NZ$0.29 B17.6%
2010 NZ$0.24 B-15.96%
2009 NZ$0.29 B
2007 -NZ$71.18 Million40.96%
2006 -NZ$50.49 Million
2003 -NZ$58.64 Million34.8%
2002 -NZ$43.5 Million89.21%
2001 -NZ$22.99 Million3.93%
2000 -NZ$22.12 Million21.76%
1999 -NZ$18.17 Million-25.61%
1998 -NZ$24.43 Million38.83%
1997 -NZ$17.59 Million-24.26%
1996 -NZ$23.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
NZ$14.45 B-2,122.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-NZ$0.32 Billion-56.46%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.82 B-215.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-NZ$59.72 Million-91.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
NZ$1.70 B-337.87%๐Ÿ‡บ๐Ÿ‡ธ USA